Breaking News...:

Promising new results on the safety of SmokeStik® electronic cigarettes, in recent small pilot study

In the summer of 2009 a novel smoking cessation pilot study was conducted. The aim of the pilot study was to examine overall cessation rates after 12 weeks in a multi-modal cessation program as well as test the safety of electronic cigarettes in terms of propylene glycol levels. This pilot represents a major first step in moving forward with a much larger randomized clinical trial testing whether the combination of multiple interventions has a positive effect on smoking cessation rates.

The current study combined 3 unique smoking cessation interventions; varenicline, cognitive- behavioral group therapy and a SmokeStik® electronic cigarette. At the end of the program all participants had quit smoking. Qualitative self- report data revealed that all participants found a multi-modal approach helpful in the smoking cessation process, including the use of an electronic cigarette. Smoking a pack a day equals 110,000 hand to mouth repetitions each year.

A Smokestik® is a unique electronic cigarette simulation that helps you positively cope with this conditioned behavior. The device is a cylindrical metal rod that closely resembles the appearance

of a cigarette.

Biological measures including lab tests conducted each month found negative blood levels of propylene glycol, and pre and post pulmonary function testing showed a marked improvement in participants overall lung functioning. For more data please visit www.smokestik.com/report. The results do suggest that multi-modal approaches may increase ones chances of quitting smoking and that SmokeStik's electronic cigarettes appear safe with respect to the inhalation of propylene glycol. More extensive experimental trials are needed.